A cost minimization analysis of olive oil vs. hyperoxygenated fatty acid treatment for the prevention of pressure ulcers in primary healthcare: A randomized controlled trial
Lupiañez-Pérez I, Morilla-Herrera JC, Kaknani-Uttumchandani S, Lupiañez-Perez Y, Cuevas-Fernandez-Gallego M, Martin-Santos F, Caro-Bautista J, Morales-Asencio JM
Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society · 5 citas
Cómo se estudió
- Diseño
- Ensayo controlado aleatorizado (indexado por PubMed)
- Estudiado en
- Personas
- Resultado principal
- Eventos clínicos como enfermedad o muerte
- Consumo medido con
- No se indica
Quién lo pagó
- Financiación
- Financiación independiente
- Gobierno
- Ministerio de Sanidad, Política Social e Igualdad
- Gobierno
- Ministerio de Sanidad, Servicios Sociales e Igualdad
- Gobierno
- Ministerio de Sanidad, Servicios sociales e igualdad
- Subvenciones
- Ministerio de Sanidad, Servicios Sociales e Igualdad (EC11‐526)
Según 3 financiadores declarados.
Publicación
- Publicado
- 2017-09-01 · Wound Repair Regen · vol. 25 · número 5 · págs. 846–851
- Editorial
- Wiley
- Citado
- 8 citas · más que el 19% de estudios similares · 0.0× el promedio de su campo
- Referencias
- 32 trabajos
- Acceso
- Lectura gratuita
- Áreas de investigación
- Pressure Ulcer Prevention and Management · Health Systems, Economic Evaluations, Quality of Life · Wound Healing and Treatments
- Palabras clave
- pressure ulcer prevention, extra virgin olive oil, cost minimization, immobilized patients, home care, primary care, non-inferiority, mobility impairment, wound care
- MeSH
- humans, fatty acids, administration, topical, retrospective studies, follow-up studies, wound healing, time factors, costs and cost analysis, drug costs, primary health care, spain, pressure ulcer, olive oil
8 autores
- Inmaculada Lupiáñez‐Pérez🇪🇸 · autor de correspondenciaAndalusian Health Service; Universidad de Málaga
- Juan Carlos Morilla Herrera🇪🇸Andalusian Health Service; Universidad de Málaga
- Shakira Kaknani‐Uttumchandani🇪🇸Universidad de Málaga
- Yolanda Lupiañez-Perez🇪🇸Andalusian Health Service; Hospital Clínico Universitario Virgen de la Victoria
- Magdalena Cuevas Fernández‐Gallego🇪🇸Andalusian Health Service; Universidad de Málaga
- Francisco Javier Martín‐Santos🇪🇸Andalusian Health Service; Universidad de Málaga
- Jorge Caro🇪🇸Andalusian Health Service
- José Miguel Morales‐Asencio🇪🇸Universidad de Málaga
Resumen
El texto original del estudio, en el idioma en que se publicó.
Pressure ulcers represent a major current health problem and cause an important economic impact on the healthcare system. Most studies on the prevention of pressure ulcers have been carried out in hospital contexts, with respect to the use of hyperoxygenated fatty acids (HOFA), and to date no studies have specifically examined the use of olive oil-based treatments.
Aim
To evaluate the cost of using extra virgin olive oil, rather than HOFA, in the prevention of pressure ulcers among persons with impaired mobility and receiving home care.
Study design
Cost minimization analysis of the results obtained from a noninferiority, triple-blind, parallel, multicenter, randomized clinical trial. Population attending primary healthcare centers in Andalusia (Spain).
Study sample
831 immobilized patients at risk of suffering pressure ulcers. These persons were included in the study and randomly assigned as follows: 437 to the olive oil group and 394 to the HOFA group. At the end of the follow-up period, the results obtained by the olive oil group were not inferior to those of the HOFA group, and did not exceed the 10% delta limit. The total treatment cost for 16 weeks was €19,758 with HOFAs and €9,566 with olive oil. Overall, the olive oil treatment was €10,192 less costly. It has been concluded the noninferiority of olive oil makes this product an effective alternative for the prevention of pressure ulcers in patients who are immobilized and in a domestic environment. This treatment enables considerable savings in direct costs.
Trial registration
Clinicaltrials.gov Identifier: NCT01595347. Date: 2011-2013.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.